Cannaray
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
34 Anyards Rd, Cobham, Surrey, KT11 2LA,...Website
www.cannaraycbd.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Cannaray
Cannaray is the only UK-based medical cannabis and CBD business with a Scientific Advisory Board comprised of specialists who are key opinion leaders covering the five areas for medical cannabis use in the UK (Multiple Sclerosis, Chemo-Induced Nausea and Vomiting, Epilepsy, Chronic Pain and Tourettes), and Cannaray is delighted to announce the below experts will be joining the existing group of world-leading experts.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cannaray your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cannaray, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cannaray is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Cannaray launches new products
Check if Cannaray has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cannaray
Funding: Get notified immidiatlly once Cannaray has new funding data
Earning: See what the market has to say on Cannaray recently announced quarterly report
Click to see if Cannaray had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Cannaray
Find more new buyers
Compare Similar Companies to Cannaray
Compare insights from companies similar to Cannaray, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cannaray
<$5M
11-50
Private
$9.6M
-
N/A
Company Profile Activity
Activity Insights
Cannaray is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cannaray is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cannaray.
Cannaray financials insights
Gather financial insights about Cannaray, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$9.6M
Cannaray Tech Stack
A closer look at the technologies used by Cannaray
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
New Hire
Executive Move
Toby Bartlett has been named Sales Grocery & Ecom Controller. Previously, Bartlett served as Senior Business Manager at Pfizer.
Funding
Funding
Funding
Cannaray News & Media
MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos
BARRIE, Ontario, May 15, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty. Ltd. (“MediPharm Labs Australia”) has secured its first European white-label cannabis supply agreement with Therismos Limited (“Therismos”), a subsidi
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cannaray
Sign Up For FreeTo access detailed company insights
Cannaray is the only UK-based medical cannabis and CBD business with a Scientific Advisory Board comprised of specialists who are key opinion leaders covering the five areas for medical cannabis use in the UK (Multiple Sclerosis, Chemo-Induced Nausea and Vomiting, Epilepsy, Chronic Pain and Tourettes), and Cannaray is delighted to announce the belo... Read More
